These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 33661301)

  • 41. Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer.
    Deng H; Liu J; Cai X; Chen J; Rocco G; Petersen RH; Brunelli A; Ng CSH; D'Amico TA; Liang W; He J
    Ann Surg; 2022 Mar; 275(3):e600-e602. PubMed ID: 34596079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgery following neoadjuvant MPV chemotherapy (mitomycin, cisplatin, vinblastine) in locally advanced (IIIa and IIIb) non-small cell lung cancer.
    Carretta A; Chiesa G; Zannini P; Villa E; Verusio C; Fumagalli F; Melloni G; Grossi A
    Eur J Cardiothorac Surg; 1994; 8(9):457-61. PubMed ID: 7811477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
    Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.
    Choi IS; Oh DY; Kwon JH; Kim SI; Park SR; Bak JY; Kim JH; Kim DW; Kim YT; Kim TY; You CK; Kim YW; Heo DS; Bang YJ; Sung SW; Park CI; Kim NK
    Jpn J Clin Oncol; 2005 Jan; 35(1):6-12. PubMed ID: 15681597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
    Takeda S; Maeda H; Okada T; Yamaguchi T; Nakagawa M; Yokota S; Sawabata N; Ohta M
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):184-9. PubMed ID: 16730452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer.
    Yang CJ; McSherry F; Mayne NR; Wang X; Berry MF; Tong B; Harpole DH; D'Amico TA; Christensen JD; Ready NE; Klapper JA
    Ann Thorac Surg; 2018 Mar; 105(3):924-929. PubMed ID: 29258674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
    Stupp R; Mayer M; Kann R; Weder W; Zouhair A; Betticher DC; Roth AD; Stahel RA; Majno SB; Peters S; Jost L; Furrer M; Thierstein S; Schmid RA; Hsu-Schmitz SF; Mirimanoff RO; Ris HB; Pless M
    Lancet Oncol; 2009 Aug; 10(8):785-93. PubMed ID: 19604722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer.
    Zhao ZR; Yang CP; Chen S; Yu H; Lin YB; Lin YB; Qi H; Jin JT; Lian SS; Wang YZ; You JQ; Zhai WY; Long H
    Oncoimmunology; 2021; 10(1):1996000. PubMed ID: 34712513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer.
    Torre W; Sierra A
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):539-44. PubMed ID: 12124570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoadjuvant sintilimab combined with chemotherapy in resectable locally advanced non-small cell lung cancer: case series and literature review.
    Yin C; Hu B; Yang X; Kou L; Tian B; Wang C; Li S; Liu B; Ge J
    World J Surg Oncol; 2023 Sep; 21(1):304. PubMed ID: 37749594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Video-assisted thoracoscopic surgery for lung cancer after induction therapy.
    Matsuoka K; Yamada T; Matsuoka T; Nagai S; Ueda M; Miyamoto Y
    Asian Cardiovasc Thorac Ann; 2018 Oct; 26(8):608-614. PubMed ID: 30249109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
    J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).
    Provencio M; Serna-Blasco R; Nadal E; Insa A; García-Campelo MR; Casal Rubio J; Dómine M; Majem M; Rodríguez-Abreu D; Martínez-Martí A; De Castro Carpeño J; Cobo M; López Vivanco G; Del Barco E; Bernabé Caro R; Viñolas N; Barneto Aranda I; Viteri S; Pereira E; Royuela A; Calvo V; Martín-López J; García-García F; Casarrubios M; Franco F; Sánchez-Herrero E; Massuti B; Cruz-Bermúdez A; Romero A
    J Clin Oncol; 2022 Sep; 40(25):2924-2933. PubMed ID: 35576508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Checkmate 77T: Perioperative chemoimmunotherapy outperforms in early-stage NSCLC.
    Brazel D; Nagasaka M
    Med; 2024 Aug; 5(8):852-855. PubMed ID: 39127033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
    Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathological complete response to neoadjuvant tislelizumab plus chemotherapy in stage IIIB small cell lung cancer: A case report and literature review.
    Zhou N; Chen Y; Huang Q; Jiang L; Liao H; Gou H; Lu Y; Che G; Zhang Y
    Front Immunol; 2023; 14():1111325. PubMed ID: 36911701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer.
    Tfayli A; Al Assaad M; Fakhri G; Akel R; Atwi H; Ghanem H; El Karak F; Farhat F; Al Rabi K; Sfeir P; Youssef P; Mansour Z; Assi H; Haidar M; Abi Ghanem A; Khalifeh I; Boulos F; Mahfouz R; Youssef B; Zeidan Y; Bejjany R; Khuri F
    Cancer Med; 2020 Nov; 9(22):8406-8411. PubMed ID: 32991781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of neoadjuvant chemotherapy on pulmonary structures: a quantitative analysis.
    Ceylan KC; Kaya SO; Samancilar O; Gursoy S; Ucvet A
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):111-5. PubMed ID: 21512976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resectable non-small cell lung cancer Adjuvant chemotherapy: slightly longer survival.
    Prescrire Int; 2016 Dec; 25(177):299-301. PubMed ID: 30758927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes.
    Beattie R; Furrer K; Dolan DP; Curioni-Fontecedro A; Lee DN; Frauenfelder T; Hoeller S; Weder W; Bueno R; Opitz I; Swanson S
    Eur J Cardiothorac Surg; 2021 Dec; 60(6):1297-1305. PubMed ID: 34331065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.